PetVivo Holdings Inc
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company's lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for … Read more
PetVivo Holdings Inc (PETV) - Total Liabilities
Latest total liabilities as of June 2025: $3.16 Million USD
Based on the latest financial reports, PetVivo Holdings Inc (PETV) has total liabilities worth $3.16 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
PetVivo Holdings Inc - Total Liabilities Trend (2011–2025)
This chart illustrates how PetVivo Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
PetVivo Holdings Inc Competitors by Total Liabilities
The table below lists competitors of PetVivo Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Rave Restaurant Group Inc
NASDAQ:RAVE
|
USA | $2.01 Million |
|
Egeplast Ege Plastik Ticaret ve Sanayi AS
IS:EPLAS
|
Turkey | TL921.98 Million |
|
Tirathai Public Company Limited
BK:TRT
|
Thailand | ฿1.86 Billion |
|
Harvard Bioscience Inc
NASDAQ:HBIO
|
USA | $63.92 Million |
|
ZUE SA
WAR:ZUE
|
Poland | zł497.54 Million |
|
Grand-Tek Technology Co. Ltd.
TWO:3684
|
Taiwan | NT$624.60 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down PetVivo Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.41 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.85 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how PetVivo Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for PetVivo Holdings Inc (2011–2025)
The table below shows the annual total liabilities of PetVivo Holdings Inc from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | $5.12 Million | +110.76% |
| 2024-03-31 | $2.43 Million | +41.74% |
| 2023-03-31 | $1.71 Million | +18.97% |
| 2022-03-31 | $1.44 Million | -16.83% |
| 2021-03-31 | $1.73 Million | +11.13% |
| 2020-03-31 | $1.56 Million | +1.48% |
| 2019-03-31 | $1.54 Million | +7.33% |
| 2018-03-31 | $1.43 Million | +32.86% |
| 2017-03-31 | $1.08 Million | -27.16% |
| 2016-03-31 | $1.48 Million | +145.83% |
| 2015-03-31 | $601.61K | +25.56% |
| 2014-03-31 | $479.15K | +86.83% |
| 2013-03-31 | $256.47K | +43.30% |
| 2012-03-31 | $178.97K | +127.33% |
| 2011-03-31 | $78.73K | -- |